Skip to main content

JHOP - Supplements

August 2022 Clinical Trials to Clinical Practice

Lung Cancer

2022 Midyear Review: Non–Small-Cell Lung Cancer

Faculty Perspectives: Through the Pharmacists’ Lens: A Deep Dive into the Practice Dynamics in Graft-versus-Host Disease

First-Line OPDIVO® (nivolumab) in Combination with Chemotherapy in Patients with Advanced or Metastatic Gastric Cancer, Gastroesophageal Cancer, and Esophageal Adenocarcinoma

Chronic Lymphocytic Leukemia

Navigating Chronic Lymphocytic Leukemia (CLL): The Critical Importance of the First 90 Days

First-Line OPDIVO® (nivolumab) in Combination with Chemotherapy in Patients with Advanced or Metastatic Gastric Cancer, Gastroesophageal Cancer, and Esophageal Adenocarcinoma

February 2022 Clinical Trials to Clinical Practice

2021 Year in Review: Advances in Dual Immunotherapy Cancer Treatments

2021 Midyear Review - Non–Small-Cell Lung Cancer

JHOP - Evolving Guidelines

Page 2 of 3
Results 11 - 20 of 25